Document is current
Any future updates will be listed below
-
Authors
Durham, Stephen R. https://orcid.org/0000-0001-5264-6207
Shamji, Mohamed H.
- License Information
-
More Information
Article History
Accepted: 8 September 2022
First Online: 17 October 2022
Competing interests
: S.R.D. reports research grants from the Immune Tolerance Network, National Institutes of Allergy and Infectious Diseases USA, Medical Research Council UK and GlaxoSmithKline; has received lecture fees from Abbott laboratories, ALK, Allergopharma, Pneumo Update GmbH and Stallergenes Greer; and has received consultancy fees from ALK, ANGANY Inc. and Revolo Biotherapeutics. M.H.S. reports grants from Leti, Regeneron, Merck, ANGANY Inc., Allergy Therapeutics and the Immune Tolerance Network; reports personal fees from Allergopharma; and reports grants and personal fees from ALK and Allergy Therapeutics.
